PubRank

Fabrice Barlesi

Author PubWeight™ 48.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer. N Engl J Med 2015 12.54
2 Randomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer. J Clin Oncol 2013 5.21
3 Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study. J Clin Oncol 2012 4.44
4 Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives. J Clin Oncol 2013 2.41
5 Phase III trial of vandetanib compared with erlotinib in patients with previously treated advanced non-small-cell lung cancer. J Clin Oncol 2011 1.88
6 Synchronous multiple primary lung cancer: an increasing clinical occurrence requiring multidisciplinary management. J Thorac Cardiovasc Surg 2007 1.33
7 Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer? Eur J Cardiothorac Surg 2005 1.28
8 A multicenter, phase 2 study of vascular endothelial growth factor trap (Aflibercept) in platinum- and erlotinib-resistant adenocarcinoma of the lung. J Thorac Oncol 2010 1.16
9 Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment. Radiat Oncol 2012 1.12
10 Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trials. Lung Cancer 2006 1.12
11 One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: an uncertain balance between risks and benefits. J Thorac Cardiovasc Surg 2005 1.00
12 Completion pneumonectomy in cancer patients: experience with 55 cases. Eur J Cardiothorac Surg 2004 0.99
13 Customized adjuvant phase II trial in patients with non-small-cell lung cancer: IFCT-0801 TASTE. J Clin Oncol 2014 0.96
14 Large cell neuroendocrine carcinoma of the lung: an aggressive disease potentially treatable with surgery. Ann Thorac Surg 2004 0.94
15 The CareGiver Oncology Quality of Life questionnaire (CarGOQoL): development and validation of an instrument to measure the quality of life of the caregivers of patients with cancer. Eur J Cancer 2011 0.92
16 Phase II, double-blinded, randomized study of enzastaurin plus pemetrexed as second-line therapy in patients with advanced non-small cell lung cancer. J Thorac Oncol 2010 0.90
17 Rebiopsy during disease progression in patients treated by TKI for oncogene-addicted NSCLC. Target Oncol 2014 0.89
18 Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesothelioma. Cancer 2007 0.88
19 Ipilimumab: its potential in non-small cell lung cancer. Ther Adv Med Oncol 2012 0.87
20 Anaphylactic reaction to pemetrexed: a case report. J Pharm Pharm Sci 2014 0.87
21 Targeted therapies in malignant pleural mesothelioma: a review of clinical studies. Anticancer Drugs 2011 0.85
22 Oral vinorelbine and cisplatin with concurrent radiotherapy after induction chemotherapy with cisplatin and docetaxel for patients with locally advanced non-small cell lung cancer: the GFPC 05-03 study. J Thorac Oncol 2011 0.85
23 Fatal pulmonary haemorrhage from a mycotic pulmonary artery aneurysm. Int J Tuberc Lung Dis 2005 0.82
24 The place of pemetrexed in the management of non-small-cell lung cancer patients. Expert Rev Anticancer Ther 2013 0.82
25 Surgical resection of liver non-small cell lung cancer metastasis: a dual weapon? Lung Cancer 2010 0.82
26 Metronomics chemotherapy: time for computational decision support. Cancer Chemother Pharmacol 2014 0.82
27 Health-related quality of life in patients with advanced nonsquamous non-small-cell lung cancer receiving bevacizumab or bevacizumab-plus-pemetrexed maintenance therapy in AVAPERL (MO22089). J Thorac Oncol 2013 0.81
28 CYP1A1 induction in the colon by serum: involvement of the PPARα pathway and evidence for a new specific human PPREα site. PLoS One 2011 0.79
29 Cytology-based treatment decision in primary lung cancer: is it accurate enough? Lung Cancer 2011 0.79
30 [β-Human chorionic gonadotropin (HCG) dosage and lung cancer: a pitfall when screening patients for clinical trials]. Bull Cancer 2012 0.79
31 Lung cancer: moving forward with tailored strategies. Lancet Oncol 2008 0.78
32 An open multicenter phase II trial of weekly docetaxel for advanced-stage non-small-cell lung cancer in elderly patients with significant comorbidity and/or poor performance status: The GFPC 02-02b study. Lung Cancer 2007 0.78
33 Targeted therapies in non-small-cell lung cancer (NSCLC): how to proceed to aim at the good target? Eur J Cardiothorac Surg 2010 0.75
34 [Which type of diagnostic and pretreatment sampling should be chosen and for which patient?]. Ann Pathol 2010 0.75
35 [Toward the multidisciplinary management of brain metastasis]. Bull Cancer 2013 0.75
36 Necitumumab for non-small cell lung cancer. Expert Opin Biol Ther 2015 0.75
37 Tumor relapse after thoracic surgery? J Thorac Oncol 2015 0.75